Hermetica Superfood Encyclopedia
The Short Answer
Russula delica contains a phenol-rich extract (RudePre) with high total phenolic and flavonoid content, water-soluble polysaccharides with anti-leishmanial activity, and norsesquiterpenoids including the novel compound russulanorol that collectively contribute to its antioxidant and antiprotozoal bioactivity. The strongest quantified in vitro finding to date is a hydroxyl radical scavenging EC50 of 0.024 mg/ml for RudePre and DPPH scavenging rates of 19.23–51.55% at concentrations up to 21.26 mg/ml, with no human clinical data currently available.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordRussula delica benefits
Milk-white Brittlegill — botanical close-up
Health Benefits
**Antioxidant Activity**: The phenol-rich RudePre fraction of R
delica demonstrates potent free-radical scavenging, with hydroxyl radical EC50 of 0.024 mg/ml and DPPH inhibition strongly correlated with total phenolic content (r=0.996), suggesting phenolics are the primary antioxidant drivers.
**Anti-leishmanial Potential**: Water-soluble polysaccharides isolated from R
delica fruiting bodies inhibit Leishmania donovani amastigotes in vitro, indicating a possible role in addressing visceral leishmaniasis, though mechanisms and effective concentrations remain incompletely characterized.
**Flavonoid-Mediated Cellular Protection**
RudePre contains quantifiable flavonoids alongside ascorbic acid, β-carotene, and lycopene, compounds collectively associated with mitigation of oxidative stress-induced cellular damage, though no cell-based mechanistic studies have been conducted specifically on R. delica.
**Sesquiterpenoid Bioactivity**: Diethyl ether extraction of R
delica fruiting bodies yields russulanorol and seven additional sesquiterpenoids including lactarorufin A, blennin C, and isolactarorufin, a chemical class known in related fungi for antimicrobial and cytotoxic properties, though specific bioassay data for these isolates from R. delica are limited.
**Thermal-Stable Antioxidant Capacity**: The antioxidant activity of R
delica extracts has been shown to resist degradation after boiling, suggesting heat-stable phenolic compounds that could theoretically retain bioactivity through conventional culinary preparation, a property relevant to both food and nutraceutical contexts.
**Putative Immunomodulatory Effects**
By analogy with structurally similar polysaccharides from related Russula species such as RP-CAP from R. pseudocyanoxantha, R. delica polysaccharides may engage TLR/NF-κB signaling in macrophages to stimulate innate immune responses, though direct evidence for this pathway in R. delica is not yet published.
Origin & History
Natural habitat
Russula delica Fr. is a widely distributed ectomycorrhizal basidiomycete mushroom found across Europe, Asia, and parts of North Africa, typically fruiting in broadleaf and coniferous forests during late summer and autumn. It grows in association with oak, beech, pine, and fir tree roots, preferring well-drained, humus-rich soils, and is commonly found partially buried in leaf litter. Unlike many edible Russula species, R. delica is considered marginally edible at best and has not been widely cultivated commercially, making it primarily a wild-harvested species of phytochemical research interest.
“Russula delica has no well-documented history of use in formalized traditional medicine systems such as Traditional Chinese Medicine, Ayurveda, or European herbal traditions, distinguishing it from more medicinally prominent fungi like Ganoderma lucidum or Lentinula edodes. In parts of southern and eastern Europe, R. delica fruiting bodies have been consumed as a food mushroom, though it is generally ranked as inferior in palatability compared to other Russula species such as R. virescens, and it is notably absent from classical European mycological texts that emphasize edible value. The species was formally described by mycologist Elias Magnus Fries in the 19th century and has since been a subject of taxonomic debate regarding its relationship to Lactarius species, with some systems previously classifying it within a broader Lactarius-allied clade. Its appearance in modern phytochemical literature is almost entirely within the context of bioactive compound screening rather than ethnomedicinal documentation, indicating it is a species whose scientific profile is being constructed de novo from contemporary laboratory research rather than validated traditional knowledge.”Traditional Medicine
Scientific Research
The scientific evidence base for R. delica is at an early preclinical stage, consisting primarily of in vitro phytochemical characterization studies with no published randomized controlled trials or observational human studies. Key published work includes isolation and structural characterization of russulanorol and related sesquiterpenoids from diethyl ether fractions of fruiting bodies, anti-leishmanial bioassay data for water-soluble polysaccharides against L. donovani amastigotes, and antioxidant profiling of the RudePre phenol-rich extract using DPPH and hydroxyl radical scavenging assays. The lipid-lowering observation referenced in the literature—a 45.2% reduction in total cholesterol in hyperlipidemic rats—was derived from a preclinical study using an unspecified Russula species polysaccharide injection, not from a controlled R. delica study, and cannot be attributed to this species. Overall, the volume of R. delica-specific research is sparse, with no quantified yields of key compounds, no dose-response pharmacokinetic data, and no studies in animal models or human subjects that would allow evidence-based dosing or efficacy conclusions.
Preparation & Dosage
Traditional preparation
**Phenol-rich Extract (RudePre)**
024 mg/ml (EC50 for hydroxyl radical scavenging) to 21
Tested in vitro at concentrations ranging from approximately 0..26 mg/ml for DPPH assays; no human-equivalent dose established.
**Water-soluble Polysaccharide Extract**
Prepared by hot-water extraction of dried fruiting body material followed by precipitation; used in anti-leishmanial bioassays at unspecified concentrations; no standard human dose defined.
**Diethyl Ether Sesquiterpenoid Fraction**
Obtained via sequential solvent partitioning of fruiting body material; yields russulanorol and related sesquiterpenoids for structural characterization only; no bioavailability or dosage data reported.
**Traditional Food Preparation**
Fruiting bodies have been consumed cooked in some European and Asian regions; boiling appears to preserve antioxidant activity based on heat stability data, though culinary use is limited due to the species' marginally edible status.
**Standardized Supplement Forms**
No commercially standardized R. delica supplement exists; no extract standardized to a defined percentage of phenolics, polysaccharides, or sesquiterpenoids has been described in published research.
**Research Note**
All dosages reported in literature are in vitro experimental concentrations and should not be interpreted as human supplemental doses.
Nutritional Profile
Russula delica, like most wild edible mushrooms, likely provides modest macronutrient content per fresh weight including protein (typically 2–4% fresh weight in Russula spp.), low fat, and carbohydrates largely in the form of chitin-rich cell wall polysaccharides and beta-glucans, though species-specific macronutrient data for R. delica are not published. The RudePre extract demonstrates measurable ascorbic acid (vitamin C), β-carotene (provitamin A), and lycopene content, all potent antioxidant micronutrients, though exact concentrations per gram of dried material are not summarized in available literature outside of tabular data. Flavonoids and total phenolics are present at levels sufficient to yield EC50 hydroxyl scavenging at 0.024 mg/ml in crude extract preparations, indicating meaningful phenolic density relative to extract mass. Bioavailability of R. delica phytochemicals has not been assessed; fungal cell wall chitin may impede absorption of intracellular bioactives unless processing steps such as boiling, grinding, or enzymatic treatment are applied.
How It Works
Mechanism of Action
The antioxidant activity of R. delica is primarily attributed to its phenolic and flavonoid constituents, which donate hydrogen atoms or electrons to neutralize reactive oxygen species including hydroxyl radicals and DPPH radicals, a mechanism reflected in the strong Pearson correlation (r=0.996) between total phenol content and DPPH scavenging in RudePre preparations. For the anti-leishmanial polysaccharides, the presumed mechanism involves disruption of L. donovani amastigote integrity or interference with parasite-host cell interactions, though specific molecular targets such as receptor binding or enzyme inhibition have not been identified in published literature for R. delica. The novel norsesquiterpenoid russulanorol and co-isolated sesquiterpenoids such as lactarorufin A and blennin C belong to a class of terpenoids that in other fungal systems have demonstrated membrane-disrupting and pro-apoptotic activity, but no receptor-level or genomic mechanism has been described for these R. delica isolates specifically. Carotenoid components including β-carotene and lycopene identified in RudePre contribute singlet oxygen quenching activity through their conjugated polyene systems, complementing the phenolic radical-scavenging mechanism.
Clinical Evidence
No clinical trials have been conducted on Russula delica in human subjects as of available literature. The existing evidence is restricted to in vitro bioassays characterizing antioxidant, anti-leishmanial, and phytochemical properties of crude and semi-purified extracts. The closest animal-model data—a 45.2% reduction in total cholesterol in hyperlipidemic rats—applies to an unspecified Russula species polysaccharide preparation and lacks sample size reporting, blinding details, or dose characterization sufficient for extrapolation. Confidence in any clinical benefit for R. delica is very low, and translation from in vitro findings to human therapeutic use cannot be supported by current data.
Safety & Interactions
No formal toxicological studies, adverse event reports, or drug interaction data exist for Russula delica extracts or isolated compounds, making comprehensive safety characterization impossible at this time. The species is considered marginally edible in traditional contexts, and there are no records of acute toxicity from food consumption in available literature, though the absence of adverse event documentation does not confirm safety, particularly for concentrated extracts or isolated fractions. No contraindications, pregnancy or lactation safety data, maximum tolerated doses, or interactions with pharmaceutical agents such as anticoagulants, immunosuppressants, or antidiabetic medications have been investigated for R. delica. Given the complete absence of clinical pharmacokinetic and toxicology data, consumption of concentrated R. delica extracts outside of controlled research settings is not advisable, and individuals with mushroom allergies or autoimmune conditions should exercise particular caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Russula delica Fr.Milk-white BrittlegillLactarius deliciosus var. delicaWeißer SpeisetäublingRudePre extract source
Frequently Asked Questions
What are the main bioactive compounds found in Russula delica?
Russula delica contains three principal classes of bioactive compounds: water-soluble polysaccharides with demonstrated anti-leishmanial activity against Leishmania donovani amastigotes, a phenol-rich fraction (RudePre) containing flavonoids, ascorbic acid, β-carotene, and lycopene with potent antioxidant properties, and sesquiterpenoids including the novel norsesquiterpenoid russulanorol alongside known compounds such as lactarorufin A, blennin C, and isolactarorufin isolated from diethyl ether extracts of the fruiting body. Exact concentrations of these compounds per gram of dried material have not been quantitatively summarized in available published research.
Is Russula delica safe to eat or use as a supplement?
Russula delica has been consumed as a marginally edible wild mushroom in parts of Europe, but no toxicological studies, drug interaction data, or maximum safe dose guidelines exist for the species or its concentrated extracts. The RudePre phenol-rich extract and polysaccharide fractions lack any published safety assessment in animals or humans. Until formal safety studies are conducted, use of R. delica extracts as dietary supplements cannot be recommended based on current evidence.
Does Russula delica have anti-leishmanial properties?
Yes, in vitro evidence indicates that water-soluble polysaccharides extracted from R. delica fruiting bodies inhibit Leishmania donovani amastigotes, the intracellular form of the parasite responsible for visceral leishmaniasis. However, the specific effective concentrations, the molecular mechanism of inhibition, and whether this activity translates to in vivo efficacy in animal models or humans have not been established in published research. These findings are preliminary and cannot yet support any clinical or therapeutic conclusions.
How does Russula delica compare to other medicinal mushrooms like reishi or lion's mane?
Russula delica is substantially less researched than established medicinal mushrooms such as Ganoderma lucidum (reishi) or Hericium erinaceus (lion's mane), which have accumulated decades of preclinical data and multiple clinical trials in humans examining immune modulation, neuroprotection, and cognitive function. R. delica's evidence base is limited to a small number of in vitro phytochemical and bioassay studies with no animal model experiments or human trials, earning it an evidence score of 2 out of 10 compared to scores of 6–8 for reishi and lion's mane. It should be considered a species of early-stage scientific interest rather than a validated functional mushroom ingredient.
What is russulanorol and why is it significant?
Russulanorol is a novel norsesquiterpenoid isolated from the diethyl ether extract of Russula delica fruiting bodies, representing a new chemical structure within the sesquiterpenoid class previously undescribed in the scientific literature. Its significance lies in expanding the known chemical diversity of Russula species and providing a new scaffold for potential bioactivity screening, as sesquiterpenoids from related fungi have shown antimicrobial, cytotoxic, and anti-inflammatory properties in other systems. However, no specific biological activity data—such as antimicrobial MICs, cytotoxicity IC50 values, or enzyme inhibition assays—have been published for russulanorol itself as of current available research.
What extraction method produces the most potent antioxidant form of Russula delica?
The RudePre fraction, extracted through phenol-rich extraction protocols, demonstrates the highest antioxidant potency with a hydroxyl radical EC50 of 0.024 mg/ml. This fraction's antioxidant capacity is strongly correlated with total phenolic content (r=0.996), indicating that extraction methods targeting phenolic compounds yield the most effective antioxidant preparations. Water-based extraction methods also preserve bioactive polysaccharides relevant to other potential health applications.
Who should consider using Russula delica supplements for antioxidant support?
Individuals seeking natural antioxidant support, particularly those concerned with oxidative stress-related conditions, may benefit from Russula delica due to its potent free-radical scavenging capacity. Those interested in medicinal mushroom supplements as part of a broader wellness protocol could incorporate R. delica as a phenol-rich option. However, anyone with existing health conditions or taking medications should consult a healthcare provider before supplementation.
How does the polysaccharide content of Russula delica fruiting bodies affect its bioavailability?
Russula delica contains water-soluble polysaccharides in its fruiting bodies, which are readily absorbed through the digestive tract and may enhance the delivery of its bioactive compounds. The presence of both polysaccharides and phenolic compounds suggests a synergistic mechanism where different extraction forms may target different absorption pathways. Consumption of whole fruiting body preparations or hot-water extracts typically preserves these polysaccharides, potentially maximizing their biological availability.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w russula-delica-russula-delica-fr curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
